Digy

 

LIT Tablets

LIT Tablets

Composition

LIT Tablets
Each film-coated tablet contains:
Levocetirizine dihydrochloride IP……………5 mg

Indications

LIT Tablets  is indicated in the symptomatic treatment of perennial and seasonal allergic rhinitis and chronic idiopathic urticaria.

Dosage and Administration

LIT Tablets  must be taken orally, swallowed whole with liquid and may be taken with or without food. It is recommended to take the daily dose in one single intake.

 

Adults and adolescents 12 years and above:
The daily recommended dose is 5 mg (1 tablet).

Children aged 6 to 12 years:
The daily recommended dose is 5 mg (1 tablet).

Duration of use:
LIT as a film-coated tablet formulation is currently available for a 6-month treatment period. For chronic urticaria and chronic allergic rhinitis, up to one year’s clinical experience is available for the racemate.

Contraindications

Hypersensitivity to levocetirizine, cetirizine, or its parent compound hydroxyzine. Patients with severe renal impairment (<10 ml/min creatinine clearance) and children 6 months to 11 years of age with impaired renal function should not be administered LIT Tablets .